A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts
PLOS One · 03.08.2026 · 21 (8) · e0344142
DOI: 10.1371/journal.pone.0344142 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 03.08.2026. Verfasst von Xiaoqing Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Vascular Endothelial Growth Factor A, Peptides. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gastric cancer is among the most common cancers and represents a major public health problem worldwide. New therapeutic strategies and drugs are needed. Anti-angiogenic agents targeting the Vascular Endothelial Growth Factor (VEGF) are used in combination therapy in the clinic, although their efficacy remains modest. We believe that these large anti-VEGF antibodies could be advantageously replaced by smaller peptides with better tissue penetration. In this study, we evaluate the efficacy of a previously described dimer peptide ligand of VEGF, D6 , in inhibiting the proliferation of gastric cancer cells and the growth of the corresponding murine xenograft. The activity of the D6 peptide in these assays was comparable to that of bevacizumab, the positive control antibody, although the peptide required repeated injections at higher molar concentrations. These promising results justify the continued optimization of the peptide dimer, currently under investigation in our laboratory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
- Université Paris Cité, CNRS, Inserm, CiTCoM, Paris, France.
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
- Université Paris Cité, CNRS, CiTCoM, Paris, France.
ORCID-Profile: Jia Jin, Elodie Olivier, Sylvain Broussy
Zitieren
APA
Ye, X., Hu, H., He, Y., Ye, F., Jin, J., Olivier, E., Gaucher, J. F., Wang, L., & Broussy, S. (2026). A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts. PLOS One, 21(8), e0344142. https://doi.org/10.1371/journal.pone.0344142
Vancouver
Ye X, Hu H, He Y, Ye F, Jin J, Olivier E, et al. A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts. PLOS One. 2026;21(8):e0344142. doi:10.1371/journal.pone.0344142
BibTeX
@article{Ye2026,
author = {Ye, Xiaoqing and Hu, Haofeng and He, Yilei and Ye, Fei and Jin, Jia and Olivier, Elodie and Gaucher, Jean-François and Wang, Lei and Broussy, Sylvain},
title = {A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0344142},
doi = {10.1371/journal.pone.0344142}
}
EUVIMED